Наранявания
About
he World Health Organisation validated the efficacy of oxyhydrogen inhalation therapy in effectively alleviating symptoms associated with coronavirus infections, offering a promising non-hospital-based treatment option for managing the disease.
Amid acute and chronic respiratory conditions, including severe cases of COVID-19, the body's primary physiological response involves synthesising distress proteins, such as chemokines and growth factors. This response, often called the cytokine storm, can rapidly increase body temperature as the immune system seeks to combat the viral infection.
Key benefits
The Research
Clinical data from the COVID-19 pandemic support the efficacy and safety of oxyhydrogen therapy, underscoring its potential as a valuable treatment modality for respiratory distress associated with viral infections
Oxyhydrogen represents a groundbreaking advancement in respiratory therapy, offering the combined therapeutic benefits of oxygen and hydrogen. This approach addresses hypoxia-related conditions by enhancing oxygen delivery to tissues. It also mitigates the risk of hyperoxia, which can occur with excessive oxygen supplementation.
COVID-19 treatment
Managing symptoms
Reduces severity
Ameliorates COVID-19
Acute post-COVID patients
Case study
Why HydroVitality?
HydroVitality offers a safe and effective method for alleviating symptoms and promoting recovery in people with COVID-19 and other respiratory illnesses. Our therapy holds promise as a cornerstone in managing acute and chronic respiratory conditions, ultimately improving outcomes, and reducing the burden on healthcare systems worldwide by targeting the underlying mechanisms driving inflammation and respiratory distress.
